Discounted for a Reason: No Quality, No Stability
Summit is cheap because the business model delivers neither quality nor stability. ROE at -270.95% and 82.7% volatility put the stock at the far end of risk. This is a pre-commercial biotech betting everything on one oncology asset. Cheap is not the same as undervalued.
Published by AssetNext · 2026-05-24
| Date | Signal | Peer score | Drawdown | 21d vs sector |
|---|---|---|---|---|
| 2026-06-08 | Profile and price weak | 34 | -51.9% | -15.4% |
| 2026-06-01 | Profile and price weak | 34 | -46.4% | -32.2% |
| 2026-05-26 | Profile and price weak | 34 | -42.0% | -22.7% |
| 2026-05-20 | Profile and price weak | 34 | -39.0% | -35.9% |
Break down SMMT's structural position across all peer dimensions with the interactive app.